to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
At-the-market offerings are used for investing in other industries, but they are just starting to pick up in life science investing. Read more on what the healthcare business should know about ATM offerings.
Pharma reps at GSK are selling their products in a new way. The emphasis is more on communicating a drug's benefits and risks than trying to sell as much as possible. Read more about this change in approach to sales.
Pharmaceutical companies are trying to adapt their marketing to an increasingly digital world. To get a handle on this environment, one company has appointed a digital advisory board of marketers from other industries.
Regenerative medicine has come a long way in recent years, leading some venture capitalists to consider investing in it. The roadblock to investing in this field is not a lack of funds, but rather a lack of a clear explanation of regenerative medicine's commercial applications, says one former venture capitalist.
The founder of a software development business had already agreed to be acquired by one company and was ready to sign the documents. Then another company came calling with a better offer. Loyal employees and a working partnership with the buyer turned out to be the crucial assets constituting the value of the business. The author concludes that you need to shop around and negotiate to find out what your company is really worth.
Question: I’ve read a few articles and blog posts over the past couple of days regarding Senator Dodd’s financial reform bill, and some of them suggest that it’s going to be more difficult for startups to raise money if the bill is signed into law. Why is that? I thought the bill was supposed to address the problems on Wall Street that led to our financial crisis.
Health IT, innovation and business models are some of the topics addressed in this Q&A session with Richard Foster, a new partner at venture capital firm Lux Capital. Read more for his views on the future of health IT and his advice for new entrepreneurs.
Angel investors have been banding together in groups, a development that benefits both the financiers and the companies they fund, says a former entrepreneur who chairs the nation's largest angel network.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.